1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Meningioma Global Clinical Trials Review, H1, 2016

Meningioma Global Clinical Trials Review, H1, 2016

  • June 2016
  • -
  • Global Data
  • -
  • 83 pages

Meningioma Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Meningioma Global Clinical Trials Review, H1, 2016" provides an overview of Meningioma clinical trials scenario. This report provides top line data relating to the clinical trials on Meningioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Meningioma Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Meningioma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Meningioma to Oncology Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Meningioma Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profile Snapshots 25
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 83

List of Tables
Meningioma Therapeutics, Global, Clinical Trials by Region, 2016* 5
Meningioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Meningioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Meningioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Meningioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Meningioma Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Meningioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 11
Proportion of Meningioma to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Meningioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Meningioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Meningioma to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Meningioma Therapeutics, Global, Clinical Trials by Phase, 2016* 16
Meningioma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 17
Meningioma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Meningioma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Meningioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Meningioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 21
Meningioma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Meningioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
Meningioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24

List of Figures
Meningioma Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Meningioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Meningioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Meningioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Meningioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Meningioma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Meningioma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 11
Proportion of Meningioma to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Meningioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Meningioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Meningioma to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Meningioma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 16
Meningioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 17
Meningioma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Meningioma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Meningioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Meningioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 21
Meningioma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Meningioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
Meningioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24
GlobalData Methodology 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Brain Tumor Therapeutics Market - Growth, Trends and Forecasts (2016 - 2021)

Global Brain Tumor Therapeutics Market - Growth, Trends and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global brain tumor therapeutics market was estimated at USD XX million in 2015 and is expected to reach USD XX million by 2021, growing at a CAGR of X% during the forecast period 2016 to 2021. Brain ...

Global Glioblastoma Treatment Drugs Market Research Report 2016

Global Glioblastoma Treatment Drugs Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Glioblastoma Treatment Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Glioblastoma Treatment Drugs industry, focusing ...

Glioblastoma multiforme (GBM) - Epidemiology Forecast To 2023

Glioblastoma multiforme (GBM) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Glioblastoma multiforme (GBM) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Glioblastoma multiforme (GBM) in seven major markets (US, France, Germany, ...


Download Unlimited Documents from Trusted Public Sources

Brain Cancer Statistics in the UK - Forecast

  • January 2017
    2 pages
  • Brain Cancer  

  • United Kingdom  

View report >

Endocrine Disease Statistics and Brain Cancer Statistics in the Netherlands

  • December 2016
    18 pages
  • Endocrine Disea...  

    Brain Cancer  

  • Netherlands  

View report >

Cancer Statistics in the US

  • December 2016
    74 pages
  • Cancer  

  • United States  

View report >

Cancer Statistics

3 months ago

Related Market Segments :

Brain Cancer
Cancer
Therapy
Oncology
Protein

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.